Attached files

file filename
EX-5.1 - OPINION OF HOGAN LOVELLS US LLP - HYPERION THERAPEUTICS INCd178027dex51.htm
EX-3.1 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - HYPERION THERAPEUTICS INCd178027dex31.htm
EX-4.2 - AMENDED AND RESTATED WARRANT ISSUED PURSUANT TO THE LOAN AND SECURITY AGREEMENT - HYPERION THERAPEUTICS INCd178027dex42.htm
S-1/A - AMENDMENT NO. 4 TO FORM S-1 - HYPERION THERAPEUTICS INCd178027ds1a.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Amendment No. 4 to Registration Statement on Form S-1 of our report dated April 13, 2012, except as to the last paragraph in Note 16, as to which the date is July 12, 2012 relating to the consolidated financial statements of Hyperion Therapeutics, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

San Jose, California

July 13, 2012